CAMBRIDGE, MA — Drawing inspiration from natural sensory systems, an MIT-led tea...
LA JOLLA (July 21, 2023)—Salk Institute researchers, in collaboration with the N...
NORMAN, OKLA. – An article describing research conducted by John Peters, Ph.D., ...
In just three years, millions of people across Michigan’s two huge peninsulas ha...
Millions of deaths and ongoing illnesses caused by the COVID-19 pandemic have pr...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the N...
A University of Texas at Arlington engineering researcher is working on defenses...
As we age, it’s more important than ever to carefully maintain our health and we...
Swiss pharmaceutical firm Novartis said on Monday that it has purchased biotechn...
Late-stage study results from BridgeBio’s phase 3 trial of its heart disease dru...
Alnylam has made significant progress in combating Alzheimer’s disease using its...
It seems like pharmaceutical layoffs are in full flow as FibroGen and Boston Sci...
Sanofi and AstraZeneca have obtained approval from the US Food and Drug Administ...
The Phase II trial for Zynlonta and Rituxan in DLBCL patients was discontinued a...
Johnson & Johnson (J&J) has reported sales of $25.53bn in Q2 of 2023, indicating...
Biotechnology firm EpiBiologics has appointed Dr Ann Lee-Karlon as CEO, presiden...
